Ligand Pharmaceuticals | Eiendeler



Assets Endring Dato
Amgen USD 91.84B 956M 2024-12
Arrowhead Research USD 1.01B 126.11M 2024-12
Baxter International USD 25.78B 894M 2024-12
Bristol-Myers Squibb USD 92.6B 1.07B 2024-12
Eli Lilly USD 78.71B 3.11B 2024-12
Gilead Sciences USD 59B 4.47B 2024-12
GlaxoSmithKline GBP 59.46B 1.41B 2024-12
Glaxosmithkline GBP 59.46B 1.41B 2024-12
Insmed USD 2.03B 27.74M 2024-12
Ionis Pharmaceuticals USD 3B 77.42M 2024-12
Ligand Pharmaceuticals USD 941.77M 13.09M 2024-12
MacroGenics USD 264.49M 63.36M 2024-09
Merck USD 117.11B 426M 2024-12
Pacira USD 1.55B 31.82M 2024-12
Pfizer USD 213.4B 6.08B 2024-12
Veracyte USD 1.3B 25.01M 2024-12



Ligand Pharmaceuticals Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.